Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The aim of this study is to develop and validate an improved, comprehensive risk assessment algorithm integrating blood RNA-based biomarkers, clinical, and patient-centered data and to assess the incremental predictive value (discrimination and reclassification) compared to a traditional risk model (change in the c-statistics for prediction of the primary endpoint).
Epistemonikos ID: 1ba5111e0be4d1dcbcd1e6b070f96c3a1facc16d
First added on: May 14, 2024